Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Obesity-related conditions

Association between γ-glutamyl transferase and metabolic syndrome: A cross-sectional study of an adult population in Beijing

L. Tao; X. Li; H. Zhu; Y. Gao; Y. Luo; W. Wang; Z. Wang; D. Chen; L. Wu; X. Guo Association between γ-glutamyl transferase and metabolic syndrome: A cross-sectional study of an adult population in Beijing International Journal of Environmental Research and Public Health
Medications Metabolic Syndrome NAFLD Obesity-related conditions

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial

D. Papamargaritis; W. Al-Najim; J. Lim; J. Crane; M. Lean; C. le Roux; B. McGowan; D. O'Shea; D. Webb; J. Wilding; M. J. Davies Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial 10
Obesity-related conditions T2DM

Pioglitazone protects HDL(2&3) against oxidation in overweight and obese men

J. McEneny; P. A. McPherson; A. McGinty; S. S. Hull; D. R. McCance; I. S. Young Pioglitazone protects HDL(2&3) against oxidation in overweight and obese men 50
Cholesterol Metabolic Health Obesity-related conditions

The impact of gastrointestinal adverse events on weight loss with liraglutide 3.0 mg as adjunct to a diet and exercise programme

C. Le Roux; D. C. W. Lau; K. Fujioka; I. D. Caterson; A. P. Cancino; C. B. Jensen; M. E. J. Lean The impact of gastrointestinal adverse events on weight loss with liraglutide 3.0 mg as adjunct to a diet and exercise programme 58
Dietary Studies Insulin resistance & diabetes Metabolic Health Obesity-related conditions Physical Activity/Exercise

Weight loss outcomes with semaglutide 2.4 mg in moderate or severe obesity in step 1 and 2

C. Le Roux; A. Aminian; R. Batterham; D. Hesse; C. Jensen; B. McGowan; A. Pakseresht; G. Rigas Sydney; F. Rubino; S. Taheri; et al. Weight loss outcomes with semaglutide 2.4 mg in moderate or severe obesity in step 1 and 2 29
Insulin resistance & diabetes Metabolic Health Obesity-related conditions

Safety and tolerability of liraglutide 3.0 mg in overweight and obese adults: the SCALE obesity and prediabetes randomised trial

C. Le Roux; D. C. W. Lau; A. Astrup; K. Fujioka; F. Greenway; A. Halpern; M. Krempf; R. Violante Ortiz; J. P. H. Wilding; C. B. Jensen; et al. Safety and tolerability of liraglutide 3.0 mg in overweight and obese adults: the SCALE obesity and prediabetes randomised trial 57
Dietary Studies Insulin resistance & diabetes Metabolic Health Obesity-related conditions Physical Activity/Exercise

Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes

C. W. Le Roux; D. C. W. Lau; K. Fujioka; F. Greenway; J. P. H. Wilding; P. B. Jacobsen; T. Skjoth; S. Madsbad Early weight loss responders to liraglutide 3.0mg had greater weight loss, regression to normoglycaemia, and reduced Type 2 diabetes development at three years vs early non-responders: SCALE Obesity and Prediabetes 34
Dietary Studies Insulin resistance & diabetes Obesity-related conditions Physical Activity/Exercise

Patient and doctor attitudes towards obesity in pregnancy

S. Lee; Y. O’brien; K. Astbury Patient and doctor attitudes towards obesity in pregnancy Irish Medical Journal
Obesity-related conditions

Overweight and obesity on the island of Ireland: an estimation of costs

A. Dee; A. Callinan; E. Doherty; C. O'Neill; T. McVeigh; M. R. Sweeney; A. Staines; K. Kearns; S. Fitzgerald; L. Sharp; F. Kee; J. Hughes; K. Balanda; I. J. Perry Overweight and obesity on the island of Ireland: an estimation of costs BMJ Open
Metabolic Health Obesity-related conditions Public Health

The positive impact of Bariatric surgery on sleep

H. Xie; L. S. Doherty; C. O’Boyle The positive impact of Bariatric surgery on sleep Irish Medical Journal
Obesity-related conditions Weight loss / Management

Older posts

Page1 Page2 Page3 Next →

Search for:

Recent Posts

ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update
ECO2023 Teaching Workshops – Registration Open!
“Addressing Obesity Together” – Press Release

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines

Privacy Policy
Site Map

©2023 ASOI